Monitoring the Impact of CPOE on Healthcare Delivery A Benefi ts Realisation Approach

Similar documents
GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

Report by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

NZ Organised Stroke Rehabilitation Service Specifications (in-patient and community)

T his article is based on a recent report from

Patient-Centered Oncology Payment: Payment Reform to Support Higher Quality, More Affordable Cancer Care (PCOP)

Mental Health Matters

Determination of Delay in :flirn Around Time (TAT) of Stat Tests and its Causes: an AKUH Experience

Monitoring EHRs to Ensure Safe and Effective Use: An Overview of What is Required. Dean F. Sittig, PhD

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:

A NEW DAWN SHEDS LIGHT ON DIABETES PSYCHOLOGY

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

Engaging People Strategy

Commissioning for Better Outcomes in COPD

Making sense of Implementation

Self-assessment checklist

Drugs Awareness. The Effects of Specific Drugs on the Body: Alcohol. The Effects of Specific Drugs on the Body: Nicotine

Vision and eye healthcare study in residential aged care facilities

Model Tender Document

National Mental Health, Well-being and Psychological Therapies the role of Clinical Psychology A briefing paper for NHS Commissioners

QUALITY IMPROVEMENT TOOLS

2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust

Diabetes Annual Report. Betsi Cadwaladr University Health Board. January 2015

Priorities for implementation research

Your Organisation: ANZCA

REPORT TO CLINICAL COMMISSIONING GROUP

2010 National Audit of Dementia (Care in General Hospitals) North West London Hospitals NHS Trust

Session Objectives 11/27/2013

Alzheimer s Society. Consultation response. Our NHS care objectives: A draft mandate to the NHS Commissioning Board.

Clinical Decision Support Technologies for Oncologic Imaging

TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN NORTHERN IRELAND NOVEMBER 2016

Australian Sonographer Accreditation Registry (ASAR) Policy & Procedure 9 - Annual Reporting Requirements for Accredited Sonography Courses

Practical Application of a CQUIN Target for Smoking Cessation Referral at Medway Maritime Hospital

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

Standard Operating Procedure: Early Intervention in Psychosis Access Times

Geriatric Emergency Management PLUS Program Costing Analysis at the Ottawa Hospital

Nature and significance of the local problem

Demonstrating the Value of Laboratory Medicine Making the case for a value proposition

2010 National Audit of Dementia (Care in General Hospitals) Chelsea and Westminster Hospital NHS Foundation Trust

Measuring the Rate of Inappropriate Lab Test Ordering

Quality Specifications for POCT

Are We Making Smart Pumps Smarter?

National Diabetes Treatment and Care Programme

Volunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland

Victorian Model of Care for Osteoarthritis of the Hip and Knee

2010 National Audit of Dementia (Care in General Hospitals)

Initial analysis of newly added data items. Do they provide insights of value?

(i) This FAQ does not deal with clinical issues (eg What is the definition of a stroke unit? or

Theory-guided mixed methods approach in improving case detection of tuberculosis in children. Jacquie Oliwa

National Osteoarthritis Strategy DRAFT for Consultation Online survey responses submitted by DAA, October 2018

THE SCOTTISH ENHANCED SERVICES PROGRAMME FOR PRIMARY AND COMMUNITY CARE ( ) Falls Prevention and Bone Health Service Specification

Where is the evidence? Demonstrating the value of laboratory medicine

COVER SHEET. Accessed from Copyright 2003 Australasian Medical Publishing Company

PCC4U. Uptake of the PCC4U Resources. Funded by the Australian Government through the National Palliative Care Program

Content. Evidence-based Geriatric Medicine. Evidence-based Medicine is: Why is EBM Needed? 10/8/2008. Evidence-based Medicine (EBM)

Diabetes in England NHS Medical Directorate. Dr Rowan Hillson MBE National Clinical Director for Diabetes

What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015

MEETING OF THE GOVERNING BODY IN PUBLIC

MOVEMBER FOUNDATION DANISH PROSTATE CANCER PROJECT REQUEST FOR APPLICATIONS

Supporting and Caring in Dementia

EMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY

Dementia Strategy MICB4336

A Framework for Optimal Cancer Care Pathways in Practice

Compare your care. How asthma care in England matches up to standards R E S P I R AT O R Y S O C I E T Y U K

Royal College of Psychiatrists in Wales Consultation Response

Analysis of Turnaround Time by Subdividing Three Phases for Outpatient Chemistry Specimens

NHS RightCare Frailty Pathway An optimal frailty system


QOF indicator area: Chronic Obstructive Pulmonary disease (COPD)

PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)

Implementing a new Orthogeriatric model to improve patient care and outcomes Aiming for Excellence!

RADIOLOGY VERSION 5. Retrospective data in full ACIR

Results of a Quality Improvement Project Aimed at Eliminating Healthcare Waste by Changing Medical Resident Test Ordering Behavior

A three month project September December 2016

Patient Outcomes in Palliative Care for South Australia

Improving documentation and coding of malnutrition a five year journey

Gregory Taddeo, DDS Dental Director

Delayed or missed follow-up of laboratory tests is

out of crisis and into recovery our community-based approach

SUBMISSION TGA CONSULTATION: INCENTIVES FOR INNOVATION PROTECTION MECHANISMS FOR EVIDENCE-BASED, PRE-ASSESSED COMPLEMENTARY MEDICINES JUNE 2018

AGED CARE alliance National Aged Care Alliance Issues Paper The Aged Care Health Care Interface

Laboratory Results Timeliness as a Quality Attribute and Strategy

Cardiac surgery in Victorian public hospitals, Public report

Ministry of Children and Youth Services. Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW

Asthma Audit Development Project: Hospital pilot information

Measure Specifications Measure Description

Aiming for Excellence in Stroke Care

ANNEX A. STATEMENT OF WORK Task Authorization (TA) 22 FOR SUB CONTRACT WITH CIMVHR

Activity Report March 2013 February 2014

South Belfast Integrated Care Partnership. Transforming Delivery of Diabetes Care 2014

Improving services for upper GI (OG) cancer Application template (Version 2)

Cleveland Clinic Laboratories Hematology Diagnostic Services. Trust in us for everything you need in a reference lab.

The audit is managed by the Royal College of Psychiatrists in partnership with:

National Diabetes Inpatient Audit (NaDIA) 2016

Challenges in Hospital Roll Outs of Comprehensive EHR Systems

The Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks

Activity Report July 2014 June 2015

Streamlining Memory Service Pathways. Guidance from the London Dementia Clinical Network

Transcription:

Monitoring the Impact of CPOE on Healthcare Delivery A Benefi ts Realisation Approach Andrew Georgiou 1, Mary Lam 2, Johanna Westbrook 1 1 Health Informatics Research and Evaluation Unit, Faculty of Health Sciences, The University of Sydney 2 Discipline of Health Informatics, Faculty of Health Sciences, The University of Sydney Abstract Objective: This paper aims to outline a suite of key indicators of Computerised Pathology Order Entry (CPOE) performance, assess their value as measurements of care delivery and their relevance to health professionals and patients. Background: CPOE systems have the potential to deliver substantial effi ciency gains along with improvements in the effectiveness and quality of patient care. However, these potential gains may be offset by poor implementation strategies and inadequate attention to problems. The implementation of CPOE should be associated with careful monitoring of their impact, particularly in areas related to the quality and safety of patient care. Methods: We draw upon results from our own research over fi ve years to focus on four key indicators of CPOE impact: laboratory turnaround times, test volumes, redundant test rate and length of stay. Each indicator is defi ned and the rationale for its measurement and potential uses identifi ed. Possible confounders to the interpretation of the indicators are assessed and a guide to the quality and reliability of data sources is provided. Results: Turnaround time (TAT) can be used to monitor different parts of the test ordering process eg, total TAT - from the time of specimen collection to test result notifi cation. Test volumes can be measured according to different parameters, eg, the number of tests per patient or per Diagnostic Resource Group to monitor adherence to electronic guidelines and test appropriateness. Redundant tests are those tests that are reordered within an inappropriate time frame and provide no additional clinical information. Length of stay can be used as an indicator of the ability of CPOE to improve effi ciency, particularly in acute, time-critical hospital departments. Conclusion: These indicators can provide valuable information by which to monitor the implementation of CPOE and drive benefi ts realisation. Keywords: Computerised Provider Order Entry, Evaluation, Laboratories, Pathology *paper peer review E1 DEST 2008 1

Objective: This paper aims to outline a suite of key indicators of Computerised Pathology Order Entry (CPOE) performance, assess their value as measurements of care delivery and their relevance to health professionals and patients. Background: Health care systems in Australia and internationally are involved in the complex task of implementing Computerised Pathology Order Entry (CPOE) systems. These systems allow clinicians to directly enter orders into computers (Doolan and Bates 2002) which allow for effi cient data management and can contribute to improved effectiveness and effi ciency of patient care (Murff and Kannry 2001). The incorporation of decision support using defi ned order sets and the provision of evidence-based guidelines can also lead to improvements in the quality of care (The Leapfrog Group for Patient Safety 2003). Despite the enormous support for CPOE systems, their diffusion has been beset by implementation problems (Ash et al. 2004; Campbell et al. 2006). It would seem imperative therefore that CPOE implementation is associated with careful monitoring of its impact, particularly in areas related to the effi ciency and effectiveness of patient care delivery, through the utilisation of robust performance indicators (quality measures). Evaluation of CPOE has an important role to play in achieving effi ciency and effectiveness benefi ts. Yet there have been few papers documenting specifi c indicators that could be valuable to this process. Methods: This paper draws upon results from our own research, as well as that of others, to outline four key indicators of CPOE impact on pathology laboratory services: turnaround time, test volume, redundant test rate and length of stay. A performance indicator is defi ned as a statistic, or other unit of information which refl ects, directly or indirectly, the performance of a system (Boyce 2002) and which can help to understand and improve the workings of a system (NHS Institute for Innovation and Improvement 2007). A template is provided for each indicator beginning with a defi nition and rationale for its measurement, its potential uses and evidence of its utilisation. Possible confounders to interpreting and understanding the indicator are assessed and a guide is provided to the quality and reliability of data sources. Results: Table 1 outlines key features of the four indicators and assesses their potential as measures of CPOE performance. Table 1. Suite of indicators for the monitoring of CPOE performance Turnaround time (TAT): Definition The time in which a laboratory can process a specimen and provide a result. TAT can be measured for different aspects of the laboratory process eg time ordered to the time a result is issued, or the time a specimen reaches the laboratory to time a result issued (Georgiou et al. 2007). TAT can also be classified by test (eg, potassium), priority (eg, urgent) or population served (eg, ward setting) (Hawkins 2007). To promote timely access to laboratory results. *paper peer review E1 DEST 2008 2

Test volumes: Definition Redundant tests: Definition Clinical satisfaction with pathology services is related to the timeliness of test results because of its effect on time to patient diagnosis and/or treatment (Howanitz and Howanitz 2001). Measure the impact of CPOE on laboratory performance and hospital efficiency. TAT can be affected by a number of institutional factors such as bed size, staffing levels, location and case mix; and by process factors like method of specimen transport (Hawkins 2007). Most laboratory services are required to collect and report TAT figures. The completeness and robustness of these data sources may be variable and depend on the data definitions employed (Australian Council on Healthcare Standards 2007). Several studies of CPOE performance using TAT report significant decreases (Mekhjian et al. 2002; Thompson et al. 2004) including a broad ranging Australian study with control which reported a significant average decrease in TAT of 15.5 minutes/test assay following CPOE implementation (Westbrook et al. 2006). TAT measures are comprised of multiple sequential steps which each have their own minimum or fastest time (eg, centrifuge spinning time) which means that normal distributions are not expected (Hawkins et al. 1999). The Australian Council on Healthcare Standards monitors TAT using a numerator of total number of test results within a specified time period (eg, less than 60 minutes) and a denominator of the total number of requests for the relevant test received by the laboratory (Australian Council on Healthcare Standards 2007) The total number of test assays requested or blood specimens taken for a given period measured through a variety of methods eg, per patient per day, per patient per Diagnostic Related Group (DRG). Test volumes can also be measured by specific test assay eg, Troponin T. To optimise efficient and effective test ordering. Test ordering volumes for pathology services continue to rise and account for a large proportion of health spending (Conyers 1999). The impact of excessive ordering is not just financial; it may lead to an increase in false positives resulting in unnecessary, expensive diagnostic examinations (Axt-Adam et al. 1993). Measure test ordering efficiency. Research in this field shows that the volume of test ordering may be affected by the type of hospital (ie, teaching or non-teaching), seniority and position of clinical staff and even by the number of doctors who see a patient (Valenstein 1996). Laboratory information systems provide the raw data for monitoring test volumes. However, for comparing test volumes by DRG, patient or by doctor, data linkage to hospital or specific department information sources may be required. Many studies of the impact of CPOE on test volumes have either reported significant decreases (Hwang et al. 2002; Wang et al. 2002) or no significant change (Ostbye et al. 1997; Westbrook et al. 2006). A major weakness of past studies has been the absence of explicit criteria to identify what is meant by inappropriate test ordering (van Walraven and Naylor 1998). Statistical Process Control methods can be a valuable means of monitoring variation in ordering patterns (Thor et al. 2007). A redundant test occurs when a test is reordered within an inappropriate time frame and provides no additional information (Bates et al. 1999; van Walraven and Raymond 2003). The measurement of redundant test rates requires the specification of tests and a time frame based on published literature or service guidelines. The redundant test rate can be calculated using the number of redundant tests for a specific test as the numerator and the total number of that test as the denominator. To improve the appropriateness of test request selection. *paper peer review E1 DEST 2008 3

Conclusion: The utilisation of performance indicators is crucial for monitoring the impact of CPOE systems and for ensuring the realisation of benefi ts from their implementation in complex hospital settings. But as the above template reveals, an indicator can never capture all the complexity of the system it purports to measure. In some cases indicators may provide succinct answers to questions. In most cases however, the best they may achieve is a picture of the variation in the system for which statistical process control methods (assessing common and special causes) can be of value (Thor et al. 2007). Acknowledgements: Redundant test rates are a modifiable component of laboratory utilisation and an area where CPOE decision support prompts and alerts can be effective (Bates et al. 1999; Georgiou and Westbrook 2006). Measure the effectiveness of test ordering. Measures of redundant test rates need to carefully consider the clinical circumstances in which a repeat test may or may not be undertaken (van Walraven and Naylor 1998). Laboratory information systems provide the raw data for monitoring test volumes. However, they may not provide the desired flexibility with which to monitor chosen criteria for redundant tests. Audits may need to be undertaken independently. There is evidence that CPOE reminders can lead to a reduction in the redundant test rate (Bates et al. 1999). There is considerable evidence that redundant test ordering is both common and costly. Monitoring the impact of CPOE on redundant test rates can make a significant contribution to reducing costs and improving laboratory utilisation. Length of stay: Definition Length of stay (LOS) represents the number of days a patient remains in hospital from admission to discharge. Average LOS is calculated by dividing the number of days stayed by the number of discharges (including deaths). LOS can also be monitored using case mix groupings or by specific hospital settings, eg, emergency department. To contribute to the efficiency and effectiveness of patient care delivery. LOS is a frequently reported indicator of hospital efficiency used to monitor the impact of organisational changes and the effect of new technology. To monitor the impact of CPOE on the efficiency of patient care processes. There is little evidence that improvement in laboratory efficiency (eg shorter TATs) leads to decreased hospital LOS. This is because TAT and LOS can be affected by institutional factors such as bed size, staffing levels, location and case mix; and by process factors eg, method of specimen transport (Hawkins 2007). Hospital Patient Administration Systems can provide LOS data as can Emergency Department Information Systems (EDIS) for emergency department LOS. Linking deidentified PAS or EDIS data with Laboratory Information Systems may allow simultaneous analysis of TAT and its effect on LOS. Most CPOE studies show no significant change in LOS when CPOE is introduced (Overhage et al. 1997; Hwang et al. 2002). Critical care and emergency care settings may be valuable domains to monitor CPOE and LOS. ED LOS is one of the major factors contributing to hospital overcrowding (Sinnott 2004) and laboratory TAT is one of the many factors which can effect ED LOS (Chan et al. 1997). This research is supported by a Department of Health and Ageing, Quality Use of Pathology Program grant. *paper peer review E1 DEST 2008 4

References: Ash, J. S., P. N. Gorman, et al. (2004), "Computerized physician order entry in U.S. hospitals: results of a 2002 Survey." J Am Med Inform Assoc. Vol. 11 No. 2, pp. 95-99. Australian Council on Healthcare Standards (2007). Australasian clinical indicator report 1998-2006; Determining the potential to improve quality 8th edition Available at http://www.achs.org.au/pdf/australasian_ CIR_8th_Edition.pdf Accessed on 3 April 2008. Axt-Adam, P., J. C. van der Wouden, et al. (1993), "Infl uencing behavior of physicians ordering laboratory tests: a literature study." Med Care Vol. 31 No. 9, pp. 784-94. Bates, D., G. Kuperman, et al. (1999), "A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests." Am J Med Vol. 106 No. February, pp. 144-150. Boyce, N. W. (2002), "Potential pitfalls of healthcare performance indicators." Med J Aust Vol. 177 No. 5, pp. 229-30. Campbell, E. M., D. F. Sittig, et al. (2006), "Types of Unintended Consequences Related to Computerized Provider Order Entry " J Am Med Inform Assoc. Vol. 13 No. 5, pp. 547-556. Chan, L., K. M. Reilly, et al. (1997), "Variables that affect patient throughput times in an academic emergency department." Am J Med Qual Vol. 12 No. 4, pp. 183-6. Conyers, R. A. J. (1999), "Modifying use of pathology services." Med. J. Aust. Vol. 170 No., pp. 8-9. Doolan, D. F. and D. W. Bates (2002), "Computerized physician order entry systems in hospitals: mandates and incentives." Health Aff Vol. 21 No. 4, pp. 180-8. Georgiou, A. and J. Westbrook (2006), "Computerised order entry systems and pathology services - a synthesis of the evidence." Clin Biochem Rev Vol. 27 No. 2, pp. 79-87. Georgiou, A., M. Williamson, et al. (2007), "The impact of computerised physician order entry systems on pathology services: a systematic review " Int J Med Inf Vol. 76 No. 7, pp. 514-29. Hawkins, H., R. Hankins, et al. (1999), "A computerized physician order entry system for the promotion of ordering compliance and appropriate test utilization." J Health Inform Manag Vol. 13 No. 3, pp. 63-72. Hawkins, R. C. (2007), "Laboratory Turnaround Time." Clin Biochem Rev Vol. 28 pp. 179-194. Howanitz, J. H. and P. J. Howanitz (2001), "Laboratory results. Timeliness as a quality attribute and strategy." Am J Clin Pathol Vol. 116 No. 3, pp. 311-5. Hwang, J. I., H. A. Park, et al. (2002), "Impact of a physician's order entry (POE) system on physicians' ordering patterns and patient length of stay." Int J Med Inf Vol. 65 No. 3, pp. 213-223. Mekhjian, H. S., R. R. Kumar, et al. (2002), "Immediate Benefi ts Realized Following Implementation of Physician Order Entry at an Academic Medical Center." J Am Med Inform Assoc. Vol. 9 No. 5, pp. 529-539. Murff, H. J. and J. Kannry (2001), "Physician Satisfaction with Two Order Entry Systems." J Am Med Inform Assoc Vol. 8 No. 5, pp. 499-511. NHS Institute for Innovation and Improvement (2007), The Good Indicators Guide: Understanding how to use and choose indicators. Available at www.institute.nhs.uk (Accessed 31 March 2008). *paper peer review E1 DEST 2008 5

Ostbye, T., A. Moen, et al. (1997), "Introducing a module for laboratory test order entry and reporting of results at a hospital ward: an evaluation study using a multi-method approach." J Med Syst Vol. 21 No. 2, pp. 107-17. Overhage, J. M., W. M. Tierney, et al. (1997), "A Randomized Trial of "Corollary Orders" to Prevent Errors of Omission." J Am Med Inform Assoc. Vol. 4 No. 5, pp. 364-375. Sinnott, M. J. (2004), "Access block viewed as a medical model." Med J Aust Vol. 181 No. 3, pp. 172-3. The Leapfrog Group for Patient Safety (2003). Fact Sheet: Computerized Physician Order Entry (CPOE). Available at: www.leapfroggroup.org/media/fi le/leapfrog-computer_physician_order_entry_fact_sheet.pdf Accessed 2 March 2006. Thompson, W., P. Dodek, et al. (2004), "Computerized physician order entry of diagnostic tests in an intensive care unit is associated with improved timeliness of service." Crit Care Med Vol. 32 No. 6, pp. 1306-1309. Thor, J., J. Lundberg, et al. (2007), "Application of statistical process control in healthcare improvement: systematic review." Qual Saf Health Care Vol. 16 No. 5, pp. 387-399. Valenstein, P. (1996), "Managing physician use of laboratory tests." Clin Lab Med Vol. 16 No. 3, pp. 749-71. van Walraven, C. and C. D. Naylor (1998), "Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits." JAMA Vol. 280 No. 6, pp. 550-8. van Walraven, C. and M. Raymond (2003), "Population-based Study of Repeat Laboratory Testing." Clin Chem Vol. 49 No. 12, pp. 1997-2005. Wang, T. J., E. A. Mort, et al. (2002), "A Utilization Management Intervention to Reduce Unnecessary Testing in the Coronary Care Unit." Arch Intern Med Vol. 162 No. 16, pp. 1885. Westbrook, J., A. Georgiou, et al. (2006), "Computerised Pathology Test Order-Entry Reduces Laboratory Turnaround Times and Infl uences Test Ordered by Hospital Clinicians: A Controlled Before and After Study." J Clin Pathol Vol. 59 No., pp. 533-36. Contact details: a.georgiou@usyd.edu.au Tel: + 61 2 9036 7331 *paper peer review E1 DEST 2008 Menu Table of Contents 6 Print Pages